---
figid: PMC5778124__fimmu-08-02012-g006
figtitle: Inhibitory nucleotide-binding oligomerization domain (NOD)-like receptors
  put the brake on NFKB activation via canonical and non-canonical pathways
organisms:
- Escherichia coli
- Staphylococcus aureus
- Mycobacterium tuberculosis
- Salmonella enterica subsp. enterica serovar Typhimurium
- Listeria monocytogenes
- Klebsiella pneumoniae
- Brucella abortus
- Homo sapiens
- Mus musculus
- Danio rerio
- gut metagenome
- Vasconcellea candicans
pmcid: PMC5778124
filename: fimmu-08-02012-g006.jpg
figlink: /pmc/articles/PMC5778124/figure/F6/
number: F6
caption: Inhibitory nucleotide-binding oligomerization domain (NOD)-like receptors
  put the brake on NF-κB activation via canonical and non-canonical pathways. Both
  NLRX1 and NLRP12 inhibit the activation of NF-κB canonical pathway following toll-like
  receptor (TLR) stimulation. Nlrx1 interacts and inhibits TNF receptor-associated
  factor (TRAF) 6, while NLRP12 inhibits the phosphorylation of IRAK-1. NLRP12 can
  also inhibit non-canonical NF-κB signaling through regulation of TRAF3 and NF-κB
  inducing kinase (NIK).
papertitle: NLR-Dependent Regulation of Inflammation in Multiple Sclerosis.
reftext: Marjan Gharagozloo, et al. Front Immunol. 2017;8:2012.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.947888
figid_alias: PMC5778124__F6
figtype: Figure
organisms_ner:
- Homo sapiens
- Mus musculus
- Danio rerio
redirect_from: /figures/PMC5778124__F6
ndex: 9a2816c7-defa-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5778124__fimmu-08-02012-g006.html
  '@type': Dataset
  description: Inhibitory nucleotide-binding oligomerization domain (NOD)-like receptors
    put the brake on NF-κB activation via canonical and non-canonical pathways. Both
    NLRX1 and NLRP12 inhibit the activation of NF-κB canonical pathway following toll-like
    receptor (TLR) stimulation. Nlrx1 interacts and inhibits TNF receptor-associated
    factor (TRAF) 6, while NLRP12 inhibits the phosphorylation of IRAK-1. NLRP12 can
    also inhibit non-canonical NF-κB signaling through regulation of TRAF3 and NF-κB
    inducing kinase (NIK).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TNF
  - CD40
  - TLR1
  - TLR2
  - TLR3
  - TLR4
  - TLR5
  - TLR6
  - TLR7
  - TLR8
  - TLR9
  - TLR10
  - MYD88
  - IRAK1
  - TRAF3
  - TRAF6
  - MAP3K14
  - MAP4K4
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
  - CUX1
  - NFKB2
  - OAS3
  - PMEL
  - SART3
  - TPX2
  - SND1
  - ASCC2
  - RELB
  - ARHGEF7
  - ASCC1
  - H3P40
  - RELA
  - SYT1
  - GORASP1
  - WNK1
  - FKBP4
  - GTF2H4
  - PMPCB
  - PSIP1
  - H3P42
  - Tnf
  - Cd40
  - Myd88
  - Irak1
  - Traf3
  - Traf6
  - Map4k4
  - Map3k14
  - Nfkbib
  - Tpx2
  - Relb
  - Cdc37
  - Lsp1
  - Nfkb1
  - Pold2
  - Dctn2
  - Rela
  - Gorasp1
  - Gtf2h4
  - Nfkb2
  - Igbp1
  - tnfrsfa
  - tnfb
  - cd40
  - kita
  - ngfra
  - myd88
  - irak1
  - traf3
  - traf6
  - nfkb2
  - relb
  - nfkb1
  - rela
---
